Log in

NYSE:ADCTADC Therapeutics Stock Price, Forecast & News

+0.87 (+1.89 %)
(As of 07/1/2020 04:00 PM ET)
Today's Range
Now: $46.81
50-Day Range N/A
52-Week Range
Now: $46.81
Volume87,300 shs
Average Volume164,694 shs
Market Capitalization$3.22 billion
P/E RatioN/A
Dividend YieldN/A
There is no company description available for ADC Therapeutics SA.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 1.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.43 out of 5 stars

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Market Cap$3.22 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive ADCT News and Ratings via Email

Sign-up to receive the latest news and ratings for ADCT and its competitors with MarketBeat's FREE daily newsletter.

ADC Therapeutics (NYSE:ADCT) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of ADC Therapeutics?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ADC Therapeutics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for ADC Therapeutics.

What price target have analysts set for ADCT?

3 equities research analysts have issued 12 month price targets for ADC Therapeutics' shares. Their forecasts range from $45.00 to $53.00. On average, they expect ADC Therapeutics' stock price to reach $49.00 in the next year. This suggests a possible upside of 4.7% from the stock's current price. View analysts' price targets for ADC Therapeutics.

Has ADC Therapeutics been receiving favorable news coverage?

News stories about ADCT stock have been trending very negative on Thursday, according to InfoTrie. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ADC Therapeutics earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about ADC Therapeutics.

Who are some of ADC Therapeutics' key competitors?

What other stocks do shareholders of ADC Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ADC Therapeutics investors own include Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Cisco Systems (CSCO), Procter & Gamble (PG), Resideo Technologies (REZI), CSX (CSX) and Garrett Motion (GTX).

When did ADC Therapeutics IPO?

(ADCT) raised $126 million in an initial public offering (IPO) on Friday, May 15th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. Morgan Stanley, BofA Securities and Cowen and Company served as the underwriters for the IPO.

What is ADC Therapeutics' stock symbol?

ADC Therapeutics trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADCT."

When did ADC Therapeutics' quiet period expire?

ADC Therapeutics' quiet period expired on Wednesday, June 24th. ADC Therapeutics had issued 12,245,631 shares in its initial public offering on May 15th. The total size of the offering was $232,666,989 based on an initial share price of $19.00. During ADC Therapeutics' quiet period, insiders and underwriters involved in the IPO were prevented from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of ADC Therapeutics?

Shares of ADCT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ADC Therapeutics' stock price today?

One share of ADCT stock can currently be purchased for approximately $46.81.

How big of a company is ADC Therapeutics?

ADC Therapeutics has a market capitalization of $3.22 billion.

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.